Inducibility of HBD-2 in acute burns and chronic conditions of the lung
The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoprot...
Gespeichert in:
Veröffentlicht in: | Burns 2003-09, Vol.29 (6), p.553-555 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 555 |
---|---|
container_issue | 6 |
container_start_page | 553 |
container_title | Burns |
container_volume | 29 |
creator | Milner, S.M Cole, A Ortega, M.R Bakir, M.H Gulati, S Bhat, S Ganz, T |
description | The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions. |
doi_str_mv | 10.1016/S0305-4179(03)00145-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73575188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0305417903001451</els_id><sourcerecordid>73575188</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMoWj9-gpKLoofVZLNpkpP4WQsFD-o5pJOsRrZZTXaF_ntTu-jRuQwMzzszPAgdUnJOCR1fPBFGeFFRoU4JOyOEVrygG2hEpVAFrYjaRKNfZAftpvROcnFJttEOLVUplFAjNJkG24Of-8Z3S9zW-OH6tiixD9hA3zk872NI2ASL4S22wQOGNljf-TaPM969Odz04XUfbdWmSe5g6Hvo5f7u-eahmD1OpjdXswKYol0hiK14VZGKKShBUWat5dxWkkjFGK9lbZySZckpGxsolQShwAAfU2XB5tgeOlnv_YjtZ-9Spxc-gWsaE1zbJy0YF5xKmUG-BiG2KUVX64_oFyYuNSV6ZVD_GNQrPZow_WNQ05w7Gg7084Wzf6lBWQaOB8AkME0dTQCf_jhOBBur1QOXa85lHV_eRZ3AuwDO-uig07b1_7zyDbqpit0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73575188</pqid></control><display><type>article</type><title>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Milner, S.M ; Cole, A ; Ortega, M.R ; Bakir, M.H ; Gulati, S ; Bhat, S ; Ganz, T</creator><creatorcontrib>Milner, S.M ; Cole, A ; Ortega, M.R ; Bakir, M.H ; Gulati, S ; Bhat, S ; Ganz, T</creatorcontrib><description>The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.</description><identifier>ISSN: 0305-4179</identifier><identifier>EISSN: 1879-1409</identifier><identifier>DOI: 10.1016/S0305-4179(03)00145-1</identifier><identifier>PMID: 12927979</identifier><identifier>CODEN: BURND8</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Anti-Infective Agents - metabolism ; Antimicrobial peptides ; beta-Defensins - metabolism ; Biological and medical sciences ; Biomarkers ; Blotting, Western - methods ; Bronchoalveolar Lavage Fluid ; Burns ; Burns, Inhalation - metabolism ; Chronic Disease ; Defensins ; Humans ; Inhalation injury ; Lung - metabolism ; Lung Diseases - metabolism ; Lung Injury ; Medical sciences ; Middle Aged ; Muramidase - metabolism ; Pneumology ; Pulmonary infections ; Respiratory system : syndromes and miscellaneous diseases ; Respiratory Tract Infections - metabolism</subject><ispartof>Burns, 2003-09, Vol.29 (6), p.553-555</ispartof><rights>2003 Elsevier Ltd and ISBI</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</citedby><cites>FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0305-4179(03)00145-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15073698$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12927979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Milner, S.M</creatorcontrib><creatorcontrib>Cole, A</creatorcontrib><creatorcontrib>Ortega, M.R</creatorcontrib><creatorcontrib>Bakir, M.H</creatorcontrib><creatorcontrib>Gulati, S</creatorcontrib><creatorcontrib>Bhat, S</creatorcontrib><creatorcontrib>Ganz, T</creatorcontrib><title>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</title><title>Burns</title><addtitle>Burns</addtitle><description>The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - metabolism</subject><subject>Antimicrobial peptides</subject><subject>beta-Defensins - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Blotting, Western - methods</subject><subject>Bronchoalveolar Lavage Fluid</subject><subject>Burns</subject><subject>Burns, Inhalation - metabolism</subject><subject>Chronic Disease</subject><subject>Defensins</subject><subject>Humans</subject><subject>Inhalation injury</subject><subject>Lung - metabolism</subject><subject>Lung Diseases - metabolism</subject><subject>Lung Injury</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muramidase - metabolism</subject><subject>Pneumology</subject><subject>Pulmonary infections</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Respiratory Tract Infections - metabolism</subject><issn>0305-4179</issn><issn>1879-1409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMoWj9-gpKLoofVZLNpkpP4WQsFD-o5pJOsRrZZTXaF_ntTu-jRuQwMzzszPAgdUnJOCR1fPBFGeFFRoU4JOyOEVrygG2hEpVAFrYjaRKNfZAftpvROcnFJttEOLVUplFAjNJkG24Of-8Z3S9zW-OH6tiixD9hA3zk872NI2ASL4S22wQOGNljf-TaPM969Odz04XUfbdWmSe5g6Hvo5f7u-eahmD1OpjdXswKYol0hiK14VZGKKShBUWat5dxWkkjFGK9lbZySZckpGxsolQShwAAfU2XB5tgeOlnv_YjtZ-9Spxc-gWsaE1zbJy0YF5xKmUG-BiG2KUVX64_oFyYuNSV6ZVD_GNQrPZow_WNQ05w7Gg7084Wzf6lBWQaOB8AkME0dTQCf_jhOBBur1QOXa85lHV_eRZ3AuwDO-uig07b1_7zyDbqpit0</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Milner, S.M</creator><creator>Cole, A</creator><creator>Ortega, M.R</creator><creator>Bakir, M.H</creator><creator>Gulati, S</creator><creator>Bhat, S</creator><creator>Ganz, T</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030901</creationdate><title>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</title><author>Milner, S.M ; Cole, A ; Ortega, M.R ; Bakir, M.H ; Gulati, S ; Bhat, S ; Ganz, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - metabolism</topic><topic>Antimicrobial peptides</topic><topic>beta-Defensins - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Blotting, Western - methods</topic><topic>Bronchoalveolar Lavage Fluid</topic><topic>Burns</topic><topic>Burns, Inhalation - metabolism</topic><topic>Chronic Disease</topic><topic>Defensins</topic><topic>Humans</topic><topic>Inhalation injury</topic><topic>Lung - metabolism</topic><topic>Lung Diseases - metabolism</topic><topic>Lung Injury</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muramidase - metabolism</topic><topic>Pneumology</topic><topic>Pulmonary infections</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Respiratory Tract Infections - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milner, S.M</creatorcontrib><creatorcontrib>Cole, A</creatorcontrib><creatorcontrib>Ortega, M.R</creatorcontrib><creatorcontrib>Bakir, M.H</creatorcontrib><creatorcontrib>Gulati, S</creatorcontrib><creatorcontrib>Bhat, S</creatorcontrib><creatorcontrib>Ganz, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Burns</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milner, S.M</au><au>Cole, A</au><au>Ortega, M.R</au><au>Bakir, M.H</au><au>Gulati, S</au><au>Bhat, S</au><au>Ganz, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</atitle><jtitle>Burns</jtitle><addtitle>Burns</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>29</volume><issue>6</issue><spage>553</spage><epage>555</epage><pages>553-555</pages><issn>0305-4179</issn><eissn>1879-1409</eissn><coden>BURND8</coden><abstract>The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12927979</pmid><doi>10.1016/S0305-4179(03)00145-1</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-4179 |
ispartof | Burns, 2003-09, Vol.29 (6), p.553-555 |
issn | 0305-4179 1879-1409 |
language | eng |
recordid | cdi_proquest_miscellaneous_73575188 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Acute Disease Adult Aged Aged, 80 and over Anti-Infective Agents - metabolism Antimicrobial peptides beta-Defensins - metabolism Biological and medical sciences Biomarkers Blotting, Western - methods Bronchoalveolar Lavage Fluid Burns Burns, Inhalation - metabolism Chronic Disease Defensins Humans Inhalation injury Lung - metabolism Lung Diseases - metabolism Lung Injury Medical sciences Middle Aged Muramidase - metabolism Pneumology Pulmonary infections Respiratory system : syndromes and miscellaneous diseases Respiratory Tract Infections - metabolism |
title | Inducibility of HBD-2 in acute burns and chronic conditions of the lung |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inducibility%20of%20HBD-2%20in%20acute%20burns%20and%20chronic%20conditions%20of%20the%20lung&rft.jtitle=Burns&rft.au=Milner,%20S.M&rft.date=2003-09-01&rft.volume=29&rft.issue=6&rft.spage=553&rft.epage=555&rft.pages=553-555&rft.issn=0305-4179&rft.eissn=1879-1409&rft.coden=BURND8&rft_id=info:doi/10.1016/S0305-4179(03)00145-1&rft_dat=%3Cproquest_cross%3E73575188%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73575188&rft_id=info:pmid/12927979&rft_els_id=S0305417903001451&rfr_iscdi=true |